Crinetics Pharmaceuticals
CRNX
CRNX
140 hedge funds and large institutions have $974M invested in Crinetics Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2.09% less ownership
Funds ownership: 102.14% → 100.05% (-2.1%)
93% less call options, than puts
Call options by funds: $32K | Put options by funds: $446K
Holders
140
Holding in Top 10
6
Calls
$32K
Puts
$446K
Top Buyers
| 1 | +$25M | |
| 2 | +$11.6M | |
| 3 | +$8.56M | |
| 4 |
Jennison Associates
New York
|
+$8.32M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$4.71M |
Top Sellers
| 1 | -$44M | |
| 2 | -$29M | |
| 3 | -$24.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.64M |
| 5 |
Walleye Capital
New York
|
-$2.16M |